DPP4 and type 1 diabetes mellitus: Overall, a meta-analysis of these four studies (shown in Figure 3(a)) suggested that the addition of DPP-4 inhibitor treatment resulted in a greater decrease (0.07%) in the HbA1c level in patients with T1DM (95% CI: −0.37%–0.23%), albeit with significant heterogeneity.